Delivering value-based medicines

Contact Us

Addressing global unmet medical needs

About Us

New and effective mechanisms of action

Pipeline

About CV6 Therapeutics

CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases. Our team has over 25 years’ experience in oncology and molecular cell biology and are using our expertise and experience in these areas to develop value-based, first-in-class medications that are scalable to address global unmet medical needs in the oncology and inflammatory disease markets



Find Out More

Our Mission

CV6 Therapeutics is developing value-based, first-in-class medications that are scalable to address global unmet medical needs in the oncology and inflammatory disease markets

News

CV6 Announces Initiation of Patient Dosing in CV6-168 Phase 1a Clinical Trial

CV6 Announces Initiation of Patient Dosing in Phase 1a Clinical Trial Evaluating the Investigational First-In-Class, Specific dUTPase Inhibitor CV6-168   Belfast, UK, 15 August 2024 – CV6 Therapeutics (NI) Ltd. (“CV6”), a clinical-stage pharmaceutical company dedicated to improving the lives of patients with cancer and inflammatory diseases by developing novel, first-in-class, small molecules targeting Uracil-DNA […]

Find Out More

Contact Us

Phone
+44 (0) 28 9097 2674
Email
information@cv6t.com
Address
  • CV6 Therapeutics Contact Address
    Health Sciences Building
    Centre for Cancer Research & Cell Biology
    97 Lisburn Road
    Belfast
    BT9 7AE
    UK